Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Triple Negative Breast Cancer Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03932526
What this trial is testing

Combined Use of Apatinib Mesylate and Vinorelbine Versus Single Use of Vinorelbine in Triple-negative Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Liaoning Cancer Hospital & Institute 184
Testing effectiveness (Phase 2)Study completedNCT04592484
What this trial is testing

A First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid Tumors

Who this might be right for
Advanced Solid Tumor
Codiak BioSciences 27
Testing effectiveness (Phase 2)Ended earlyNCT04986852
What this trial is testing

Olinvacimab With Pembrolizumab in Patients With mTNBC

Who this might be right for
Metastatic Triple-Negative Breast Cancer
PharmAbcine 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT07471815
What this trial is testing

Camrelizumab Plus Risedronate and Chemotherapy for Triple-Negative Breast Cancer: An Exploratory Clinical Study on Mechanisms and Efficacy

Who this might be right for
Breast Cancer Triple Negative Breast Cancer
Harbin Medical University 30
Not applicableNot Yet RecruitingNCT07523789
What this trial is testing

Comparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBC

Who this might be right for
TNBC, Triple Negative Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 201
Early research (Phase 1)Study completedNCT01281150
What this trial is testing

Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Adult Solid NeoplasmEstrogen Receptor NegativeEstrogen Receptor Positive+8 more
National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)WithdrawnNCT02539017
What this trial is testing

The Clinical Significance of Cellular Immune Adjuvant Therapy of Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Neoplasms
First Affiliated Hospital Xi'an Jiaotong University
Testing effectiveness (Phase 2)Study completedNCT03709446
What this trial is testing

Leflunomide in Previously Treated Metastatic Triple Negative Cancers

Who this might be right for
Breast NeoplasmsBreast DiseasesMetastatic Triple Negative Breast Cancer
Joseph Sparano 17
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07292142
What this trial is testing

FMT in Triple Negative Breast Cancer Guided by ctDNA

Who this might be right for
Breast Cancer
Jewish General Hospital 125
Testing effectiveness (Phase 2)Study completedNCT02689427
What this trial is testing

Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer

Who this might be right for
Invasive Breast CarcinomaStage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7+9 more
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT03742102
What this trial is testing

Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Neoplasms
AstraZeneca 243
Testing effectiveness (Phase 2)Ended earlyNCT04216472
What this trial is testing

Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN Alterations

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+19 more
M.D. Anderson Cancer Center 6
Early research (Phase 1)Study completedNCT03205176
What this trial is testing

AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas

Who this might be right for
Malignant Solid TumorsLymphomaOvarian Cancer+3 more
AstraZeneca 49
Early research (Phase 1)Ended earlyNCT02698176
What this trial is testing

A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Advanced Solid Tumors (MK-8628-006)

Who this might be right for
NUT Midline Carcinoma (NMC)Triple Negative Breast Cancer (TNBC)Non-small Cell Lung Cancer (NSCLC)+1 more
Merck Sharp & Dohme LLC 13
Early research (Phase 1)Active Not RecruitingNCT04606472
What this trial is testing

SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 60
Very early researchEnded earlyNCT03361800
What this trial is testing

Window of Opportunity Trial of Entinostat in Patients With Newly Diagnosed Stage I-IIIC,TNBC

Who this might be right for
Breast CancerInvasive Breast CancerER-Negative PR-Negative HER2-Negative Breast Cancer
UNC Lineberger Comprehensive Cancer Center 5
Not applicableUnknownNCT04145947
What this trial is testing

Evaluation of Prognostic Monitoring for Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer
Peking Union Medical College Hospital 200
Not applicableStudy completedNCT01251900
What this trial is testing

BRCA Mutations in Latinas

Who this might be right for
Breast Neoplasms
National Cancer Institute (NCI) 266
Testing effectiveness (Phase 2)Study completedNCT01790932
What this trial is testing

BKM120 For Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 50
Testing effectiveness (Phase 2)Study completedNCT03761914
What this trial is testing

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

Who this might be right for
Acute Myelogenous LeukemiaOvarian CancerColorectal Cancer+2 more
Sellas Life Sciences Group 26
Next Page